Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FYW76
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,273
Award facts
- Contract value 100% obligated
- $9,273.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $9,273.12 to DMS Pharmaceutical Group Inc. for the supply of Actemra Actpen 162 mg/0.9 ml injections. The contract, issued on June 4, 2025, with an ultimate completion date of June 26, 2025, represents a standard procurement action with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the delivery at its facility location.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes firm fixed-price orders for pharmaceutical supplies supporting military health facilities. The company serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide. Actemra (tocilizumab) is a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions, making this delivery order consistent with the contractor's established portfolio of specialty pharmaceutical products for military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FYW76?
SPE2DB25FYW76 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FYW76 worth?
The government has obligated $9,273 on SPE2DB25FYW76.
Is contract SPE2DB25FYW76 an order under another contract?
Yes. SPE2DB25FYW76 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYW76 competed?
The extent of competition for SPE2DB25FYW76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award